We are live on ! Find out more
GC

Grimes & Company Portfolio holdings

AUM $4.62B
1-Year Est. Return 29.71%
This Fund
S&P 500
This Quarter Est. Return
+2.42%
1 Year Est. Return
+29.71%
3 Year Est. Return
+66.17%
5 Year Est. Return
+73.59%
10 Year Est. Return
+287.63%
AUM
$356M
AUM Growth
+$21.4M
Cap. Flow
+$13.5M
Cap. Flow %
3.78%
Top 10 Hldgs %
21.9%
Holding
167
New
14
Increased
82
Reduced
36
Closed
17

Top Buys

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$6.43M
2
SLB icon
SLB Ltd
SLB
+$3.78M
3
PETM
PETSMART INC
PETM
+$3.64M
4
TSM icon
TSMC
TSM
+$3.11M
5
TM icon
Toyota
TM
+$2.51M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$6.53M
2
KDP icon
Keurig Dr Pepper
KDP
+$4.88M
3
FFIV icon
F5
FFIV
+$3.47M
4
CA
CA, Inc.
CA
+$2.97M
5
MDT icon
Medtronic
MDT
+$2.03M

Sector Composition

Rank Sector Weight
1 Technology 25.97%
2 Healthcare 12.43%
3 Industrials 12.11%
4 Energy 9.92%
5 Financials 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
101
Bristol-Myers Squibb
BMY
$132B
$387K 0.11%
7,447
+1,900
+34% +$101K
EV
102
DELISTED
Eaton Vance Corp.
EV
$386K 0.11%
10,110
+1,710
+20% +$65.9K
ALE
103
DELISTED
Allete
ALE
$382K 0.11%
+7,280
New +$364K
BSFT
104
DELISTED
BroadSoft, Inc.
BSFT
$362K 0.1%
13,541
BIIB icon
105
Biogen
BIIB
$30.7B
$360K 0.1%
1,178
+215
+22% +$68.2K
EPD icon
106
Enterprise Products Partners
EPD
$82.5B
$330K 0.09%
9,512
-1,200
-11% -$39.8K
DXPE icon
107
DXP Enterprises
DXPE
$2.4B
$328K 0.09%
+3,450
New +$347K
PCAR icon
108
PACCAR
PCAR
$70.4B
$312K 0.09%
6,933
RDS.A
109
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$312K 0.09%
4,275
-1,323
-24% -$94.6K
CMCSA icon
110
Comcast
CMCSA
$84B
$311K 0.09%
12,440
-2,496
-17% -$65K
ES icon
111
Eversource Energy
ES
$27.8B
$311K 0.09%
6,839
-99
-1% -$4.32K
MRK icon
112
Merck
MRK
$321B
$311K 0.09%
5,735
+95
+2% +$4.92K
TXN icon
113
Texas Instruments
TXN
$255B
$308K 0.09%
6,536
+1,602
+32% +$70.7K
CAT icon
114
Caterpillar
CAT
$373B
$304K 0.09%
3,060
+7
+0.2% +$660
DD
115
DELISTED
Du Pont De Nemours E I
DD
$300K 0.08%
4,704
+6
+0.1% +$367
HON icon
116
Honeywell
HON
$76.7B
$298K 0.08%
+3,571
New +$296K
BEAM
117
DELISTED
BEAM INC COM STK (DE)
BEAM
$292K 0.08%
3,500
CHKP icon
118
Check Point Software Technologies
CHKP
$13.1B
$287K 0.08%
4,250
NEE icon
119
NextEra Energy
NEE
$183B
$287K 0.08%
12,012
+872
+8% +$19.8K
PEG icon
120
Public Service Enterprise Group
PEG
$38.6B
$278K 0.08%
7,292
+20
+0.3% +$690
ETN icon
121
Eaton
ETN
$150B
$264K 0.07%
3,509
WRB icon
122
W.R. Berkley
WRB
$27.2B
$251K 0.07%
20,368
BP icon
123
BP
BP
$114B
$249K 0.07%
6,338
+16
+0.3% +$631
AFL icon
124
Aflac
AFL
$64.8B
$248K 0.07%
7,874
+396
+5% +$12.6K
SAM icon
125
Boston Beer
SAM
$1.93B
$248K 0.07%
1,013
+13
+1% +$2.96K

Similar funds

Grimes & Company's Q1 2014 Portfolio in Review

As of Q1 2014, Grimes & Company held 167 positions worth $356M, up 6.4% from $335M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Grimes & Company deployed $13.5M of net new capital in Q1 2014, opening 14 new positions and adding to 82 existing holdings. Its largest new stake was Gen Digital: 300,398 shares worth $6M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was AstraZeneca, an estimated $6.53M trimmed.

  • Grimes & Company's largest Q1 2014 buy was Gen Digital: 300,398 shares worth $6M.
  • Grimes & Company added most to SLB Ltd in Q1 2014, an estimated $3.78M increase.
  • Grimes & Company's biggest Q1 2014 reduction was AstraZeneca, cutting an estimated $6.53M.
  • Grimes & Company fully exited F5 in Q1 2014, selling an estimated $3.47M.
  • Grimes & Company's ten largest holdings make up 22% of its $356M portfolio in Q1 2014.
  • Grimes & Company opened 14 new positions and closed 17 in Q1 2014.
  • Grimes & Company's portfolio value rose 6.4% quarter-over-quarter to $356M.

Based on Grimes & Company's 13F filing for Q1 2014, filed 1 May 2014.